In this work, we carried out a screening of GluA3 autoantibodies in a large series of FTD patients and the neurobiological effect of anti-GluA3 autoantibodies was investigated in rat hippocampal neuronal primary cultures and in neurons differentiated from human induced pluripotent stem cells (hiPSCs). The gene discussed is GRIA3; the disease is frontotemporal dementia.